STRATA Skin Sciences Inc (SSKN) - Total Liabilities
Based on the latest financial reports, STRATA Skin Sciences Inc (SSKN) has total liabilities worth $27.61 Million USD as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check how resilient are STRATA Skin Sciences Inc's assets to evaluate the company's liquid asset resilience ratio.
STRATA Skin Sciences Inc - Total Liabilities Trend (2002–2025)
This chart illustrates how STRATA Skin Sciences Inc's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see total assets of STRATA Skin Sciences Inc.
STRATA Skin Sciences Inc Competitors by Total Liabilities
The table below lists competitors of STRATA Skin Sciences Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Hamak Gold Ltd
LSE:HAMA
|
UK | GBX1.11 Million |
|
XLMedia PLC
LSE:XLM
|
UK | GBX24.32 Million |
|
t42 IoT Tracking Solutions PLC
LSE:TRAC
|
UK | GBX6.75 Million |
|
Carisma Therapeutics Inc.
NASDAQ:CARM
|
USA | $7.42 Million |
|
FAT Brands Inc
NASDAQ:FATBW
|
USA | $1.79 Billion |
|
Chordate Medical Holding AB
ST:CMH
|
Sweden | Skr4.14 Million |
Liability Composition Analysis (2002–2025)
This chart breaks down STRATA Skin Sciences Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See SSKN net asset quality score to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.58 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 9.50 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.90 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how STRATA Skin Sciences Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for STRATA Skin Sciences Inc (2002–2025)
The table below shows the annual total liabilities of STRATA Skin Sciences Inc from 2002 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $27.61 Million | -11.45% |
| 2024-12-31 | $31.18 Million | +6.33% |
| 2023-12-31 | $29.33 Million | -3.66% |
| 2022-12-31 | $30.44 Million | +43.73% |
| 2021-12-31 | $21.18 Million | +1.40% |
| 2020-12-31 | $20.89 Million | +11.75% |
| 2019-12-31 | $18.69 Million | +14.95% |
| 2018-12-31 | $16.26 Million | -0.78% |
| 2017-12-31 | $16.39 Million | -42.45% |
| 2016-12-31 | $28.47 Million | -19.30% |
| 2015-12-31 | $35.28 Million | +352.72% |
| 2014-12-31 | $7.79 Million | +33.55% |
| 2013-12-31 | $5.84 Million | +77.14% |
| 2012-12-31 | $3.29 Million | +107.74% |
| 2011-12-31 | $1.59 Million | -11.42% |
| 2010-12-31 | $1.79 Million | -1.15% |
| 2009-12-31 | $1.81 Million | +18.36% |
| 2008-12-31 | $1.53 Million | +14.50% |
| 2007-12-31 | $1.34 Million | +15.03% |
| 2006-12-31 | $1.16 Million | +26.78% |
| 2005-12-31 | $916.34K | -91.39% |
| 2004-12-31 | $10.65 Million | +1537.88% |
| 2003-12-31 | $650.00K | -87.00% |
| 2002-12-31 | $5.00 Million | -- |
About STRATA Skin Sciences Inc
STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, China, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. It operates through Dermatology Recurring Procedures and Dermatology Procedures Equipment segments. The company offers XTRAC excimer … Read more